S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

ABSTRACT:

SUBMITTER: Mateos M 

PROVIDER: S-EPMC10428427 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature